Melanoma Does Not Discriminate: Enrolling in MoleSafe's Early Detection Screening Program Can Save Your Life

Melanoma, the deadliest form of skin cancer, affects the young, the old, the fair skinned and the dark skinned. Contrary to the common belief that only fair-skinned individuals can be affected, dark skin does not indicate immunity to skin cancer. Although Caucasians are the primary targets for skin cancer, people with darker skin tones are also at risk. Melanoma is usually more deadly for people with darker skin because they usually take fewer precautions and are commonly misdiagnosed or diagnosed too late. Although it can be extremely deadly, melanoma is also highly preventable with some lifestyle stages and by enrolling in MoleSafe’s early detection screening program, located at 60 Essex Street in Milburn, NJ.

This misconception in part derives from the fact that people who have a darker complexion have more melanin in their skin. Melanin, which gives color to your skin, also acts as a natural shield against damaging sunrays, thus making darker-skinned people less prone to UV radiation damage and sun burns. However, that does not mean that people with darker skin tones are invincible to skin cancer, because this natural protection is not flawless.

Several factors that can lead to a high risk of developing skin cancer, regardless of a person’s skin color include:

· Overexposure in the sun

· A history of sunburns

· The presence of moles and/or skin lesions

· Family history of skin cancer

· Living in high-altitude climates or near the equator

· A weakened immune system

· Overexposure to radiation, or other substances such as arsenic

Because melanoma, one of the fastest-growing cancers in the U.S. does not discriminate, people of all skin colors need to be aware of its risk factors and preventative measures to help lower their risk. Self-exams can help identify potential skin cancers early, but MoleSafe’s melanoma screening and surveillance program is the most advanced and comprehensive program that identifies melanoma at the earliest possible stages, when survival rates are highest. Compared to the capabilities of dermatologists, MoleSafe’s program excels, detecting melanoma at an average of just 0.6mm thickness, compared to dermatologists’ detection at an average of 1.3mm thickness. MoleSafe’s program also results in up to 95 percent fewer incisions, which means that MoleSafe patients endure less cutting to remove moles and the number of unnecessary biopsies is greatly reduced.

The only way to effectively manage melanoma is prevention and early detection. MoleSafe is currently running a Millburn Appreciation Program and is offering all Millburn residents, business owners and employees a 20 percent discount off their initial screening to detect skin cancer at its earliest stages.

For more information on MoleSafe, or to schedule your appointment today, please visit www.molesafe.com/Millburn or call 1-877-326-6518. If you live, work or own a business in Millburn, mention the “Millburn Appreciation Program” when booking, and you will receive 20 percent off your first visit.

About MoleSafe Inc.

MoleSafe is the world’s most advanced melanoma screening and surveillance program. Headquartered in Millburn, New Jersey, with its flagship location at New York University’s Langone Medical Center, MoleSafe’s comprehensive program incorporates a suite of advanced melanoma detection and diagnosis tools and technology, including total body photography, digital dermoscopy, and digital serial monitoring, to result in earlier detection of melanoma and reduce the unnecessary removal of benign lesions. Through its partnership with MoleMap, which offers the same screening services in Australia and New Zealand, more than 40 facilities have been established globally, and thousands of melanomas and other skin cancers have been diagnosed from more than 150,000 telemedicine consultations. For more information about MoleSafe, please visit www.molesafe.com/Millburn.